The SUBITO trial, presented by Rianne L Seefat and colleagues in The Lancet Oncology,1 revisits the long-standing debate surrounding high-dose chemotherapy with autologous stem-cell rescue in patients ...
The worsening outbreak of Ebola virus disease caused by Bundibugyo virus (Orthoebolavirus bundibugyoense; BDBV) in DR Congo and Uganda,1–3 declared a Public Health Emergency of International Concern ...
For more than 10 years, the stroke research community has sought and investigated drugs that could enhance or strengthen the ...
The Iran conflict has disrupted supplies of cisplatin and carboplatin, leading to treatment interruption for patients. Samaan Lateef reports from Mumbai.
The MASAI trial1 concludes that artificial intelligence (AI)-supported screening “can efficiently improve screening performance” and “may be considered for implementation in clinical practice”.
In the midst of the 2026 men's football World Cup, the paradox of using the world's most popular sport to normalise and promote alcohol consumption has resurfaced. Although it is understandable that ...
Dedicated treatment facilities are a cornerstone of an Ebola virus disease outbreak response, but conditions are extremely ...
Our findings provide the first robust national-level evidence, albeit observational, that high HPV vaccination coverage is associated with a substantial reduction in cervical cancer deaths. This is ...
Despite important gains since 2010, including in HIV prevention, progress remains uneven for populations with persistent ...
The Global Fund to Fight AIDS, Tuberculosis and Malaria formally launched its search for a new Executive Director in February, 2026, with the Board expected to make its appointment in October, 2026.1 ...
The city of São Paulo, Brazil, is involving citizens in an innovative project to combat the health dangers of excessive heat. Jacqui Thornton reports.
The global medical and public health community needs to be aware of a dire threat—and of the opportunities to challenge it—posed by a new rule proposed on May 29, 2026, by the second Trump ...